2021 18th Annual Biopharma Manufacturing Survey--BioPlan

1. Introduction

2021 BioPlan's 18th Annual Survey--Biopharmaceutical Manufacturing

Participate in the biopharma industry's most comprehensive benchmarking analysis! Now in our 18th year, we continue to analyze advances in bioprocessing, new technologies and emerging trends.

Question Title

* 1. TRENDS
What is the SINGLE most important biomanufacturing trend/operational area the industry must focus efforts on in 2021?

Fill-Finish Technologies

Continuous BioProcessing - Downstream

Upstream: Processing Advances

Covid-19 pandemic response

Process design and scale-up

Continuous BioProcessing - Upstream

Manufacturing Cost Reductions

Viral and Gene Therapies

Manufacturing Productivity/Efficiency

Downstream: Processing Advances

Single-Use Systems: Implementation and Integration

Outsourcing

Biosimilars/Biogenerics

Materials Sourcing/Raw Materials Management

Automation

Single-Use Systems: Better devices

Capacity Issues

Cell Therapy

Question Title

* 1. TRENDSWhat is the SINGLE most important biomanufacturing trend/operational area the industry must focus efforts on in 2021?

* 1. TRENDS
What is the SINGLE most important biomanufacturing trend/operational area the industry must focus efforts on in 2021?